TY - JOUR
TI - Multimodal Imaging for the Assessment of Geographic Atrophy in Patients with "Foveal" and "No-Foveal" Sparing
AU - Kabanarou, S.A.
AU - Bontzos, G.
AU - Xirou, T.
AU - Kapsala, Z.
AU - Dimitriou, E.
AU - Theodossiadis, P.
AU - Chatziralli, I.
JO - Ophthalmic Research
PY - 2021
VL - 64
TODO - 4
SP - 675-683
PB - S Karger AG
SN - 0030-3747, 1423-0259
TODO - 10.1159/000512103
TODO - accuracy;  adult;  age related macular degeneration;  aged;  Article;  autofluorescence;  clinical article;  controlled study;  cross-sectional study;  diagnostic accuracy;  eye disease assessment;  female;  geographic atrophy;  gold standard;  human;  male;  multimodal imaging;  optical coherence tomography angiography;  thermography;  diagnostic imaging;  fluorescence angiography;  geographic atrophy;  macular degeneration;  multimodal imaging;  optical coherence tomography;  retina fovea, Fluorescein Angiography;  Fovea Centralis;  Geographic Atrophy;  Humans;  Macular Degeneration;  Multimodal Imaging;  Tomography, Optical Coherence
TODO - Introduction: The aim of the study was to evaluate the applicability of optical coherence tomography (OCT) angiography (OCTA) for measuring geographic atrophy (GA) areas in age-related macular degeneration (AMD) patients with "foveal"and "no-foveal"sparing disease and compare it to other imaging modalities. Methods: A multimodal imaging protocol was applied, using infrared (IR) imaging, fundus autofluorescence (FAF), OCTA, and en-face OCT in 35 eyes of 23 AMD patients with GA. Patients were classified into 2 groups, with and without foveal sparing disease. GA area measurements for all imaging modalities were compared for each group separately. Results: The measured GA area was estimated to be 6.68 ± 3.18 mm2 using IR; 6.99 ± 3.09 mm2 using FAF; 6.56 ± 3.11 mm2 using OCTA, and 6.65 ± 3.14 mm2 using en-face OCT. There was no statistically significant difference in the GA area between different modalities (p = 0.977). When separate analysis was conducted for patients with "foveal"and "no-foveal"sparing disease, although GA measurements in FAF imaging displayed higher numerical values than the other modalities, especially in patients with foveal sparing, no statistically significant difference in the GA area was found between the different imaging modalities in either group (p = 0.816 for foveal sparing; p = 0.992 for no-foveal sparing group). Conclusions: OCTA can be reliably used in the assessment of GA in AMD patients with and without foveal sparing disease. For both groups, measurements are comparable to IR, en-face OCT, and FAF, despite the fact that the latter recorded larger area of GA, mainly in the foveal sparing cases. © 2020 S. Karger AG, Basel. Copyright: All rights reserved.
ER -